Find out how researchers at Baylor Scott & White Health are engineering CAR-T to recognize specific antigens located on the surface of targeted cancer cells.
We recently received a $5.13 million national grant to fund research seeking to detect pancreatic cancer early by testing just a small sample of the patient’s blood.
Recent investigation into the potential cause of acute kidney injury after PCI and intervention may alter the accepted clinical belief that contrast media is the culprit.
We’ve created a transformative model for the health care industry that eliminates waste, improves coordination of care and helps us better manage chronic disease.
Baylor Scott & White has both clinical and research campuses for the Texas A&M Health Science Center (HSC) College of Medicine. In addition, we are an accredited provider for the Accreditation Council for Continuing Medical Education (ACCME).
Our extensive network of 48 hospitals and more than 900 patient care sites – including specialized centers, institutes and regional clinics – offers your patients a full range of medical expertise.
We define features of complex regional pain syndrome in a 35-year-old patient, outline its treatment options and describe a course of CRPS management.
Register for this forward facing event featuring breakthroughs in biomarkers, imaging and prevention of Alzheimer's disease.
We currently have a study comparing the effectiveness, safety and tolerability of SAR341402, insulin aspart, with that of the currently marketed insulin analog insulin aspart.